The HLEG is an initiative of representatives of six national bodies (with a policy interest or substantial research activities in low dose risk research) and the EURATOM research programme.

The objectives of the HLEG are:

• To formulate and agree the policy goals to be addressed by low dose risk research;
• To develop a strategic research agenda and road map for low dose risk research in Europe;
• To specify the essential elements of and next steps for establishing a sustainable operational framework for low dose risk research in Europe.

Further details are given in TOR of the HLEG.

The HLEG has decided that public consultation on the draft report should take place prior to final publication. The consultation process has closed. The final report is now available.